Role of PI3K-AKT-mTOR and Wnt Signaling Pathways in Transition of G1-S Phase of Cell Cycle in Cancer Cells

Abstract

The PI3K-Akt pathway together with one of its downstream targets, the mechanistic target of rapamycin (mTOR; also known as the mammalian target of rapamycin) is a highly deregulated pathway in cancers. mTOR exists in two complexes, mTORC1 and mTORC2. Akt phosphorylated at T308 inhibits TSC1/2 complex to activate mTORC1; mTORC2 is recognized as the kinase phosphorylating Akt at S473. Inhibition of autophagy by mTORC1 was shown to rescue disheveled (Dvl) leading to activation of Wnt pathway. Cyclin D1 and the c-Myc are activated by the Wnt signaling. Cyclin D1 is a key player in initiation of cell cycle. c-Myc triggers metabolic reprograming in G1 phase of cell cycle, which also activates the transcription factors like FoxO and p53 that play key roles in promoting the progression of cell cycle. While the role of p53 in cancer cell metabolism in arresting glycolysis and inhibition of pentose phosphate pathway has come to be recognized, there are confusions in the literature on the role of FoxO and that of rictor. FoxO was shown to be the transcription factor of rictor, in addition to the cell cycle inhibitors like p21. Rictor has dual roles; inhibition of c-Myc and constitution of mTORC2, both of which are key factors in the exit of G1-S phase and entry into G2 phase of cell cycle. A model is presented in this article, which suggests that the PI3K-Akt-mTOR and Wnt pathways converge and regulate the progression of cell cycle through G0-G1-S-phases and reprogram the metabolism in cancer cells. This model is different from the conventional method of looking at individual pathways triggering the cell cycle.

Targeting the Neurokinin-1 Receptor Compromises Canonical Wnt Signaling in Hepatoblastoma

“…This work clearly showed that the phosphorylation of TSC2 by GSK3b is significantly suppressed by Wnt signaling. These findings suggest that components of the mTOR pathway can potentially be targets for diseases linked to hyperactive Wnt signaling, including cancer (37,38).…”

MicroRNA-301a promotes cell proliferation via PTEN targeting in Ewing's sarcoma cells

“…Akt activates the mTOR signaling pathway (37) and represses p21, as well as Bax, to enhance cell proliferation preventing apoptosis (38,39). Therefore, Akt downregulation by PTEN in ES cells induced the upregulation of p21 and Bax, which might have resulted in cell cycle inhibition and apoptosis in ES cells.…”

Resolvin D2 Supports MCF-7 Cell Proliferation via Activation of Estrogen Receptor

“…It is well established that cell survival and cell proliferation are mediated predominantly through the PI3K/Akt and the ERK1/2 MAPK pathways. These kinases are often found to be highly deregulated in cancer, and their activation will ultimately result in upregulation of CCND1 expression (Castaneda et al, 2010;Vadlakonda et al, 2013). Moreover, they are also important for ER activity in some tumors because they phosphorylate and thereby activate both E 2 -free and E 2 -bound ER (Renoir et al, 2013).…”